Cargando…
Development of New Cancer Treatment by Identifying and Focusing the Genetic Mutations or Altered Expression in Gynecologic Cancers
With the advent of next-generation sequencing (NGS), The Cancer Genome Atlas (TCGA) research network has given gynecologic cancers molecular classifications, which impacts clinical practice more and more. New cancer treatments that identify and target pathogenic abnormalities of genes have been in r...
Autores principales: | Tang, Yun-Hsin, Lin, Chiao-Yun, Lai, Chyong-Huey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535522/ https://www.ncbi.nlm.nih.gov/pubmed/34680987 http://dx.doi.org/10.3390/genes12101593 |
Ejemplares similares
-
Rare Subtype of Endometrial Cancer: Undifferentiated/Dedifferentiated Endometrial Carcinoma, from Genetic Aspects to Clinical Practice
por: Tung, Hsiu-Jung, et al.
Publicado: (2022) -
Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies
por: Chao, Angel, et al.
Publicado: (2017) -
Genetic alterations and their therapeutic implications in epithelial ovarian cancer
por: Lapke, Nina, et al.
Publicado: (2021) -
Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells
por: Lin, Chiao-Yun, et al.
Publicado: (2016) -
Molecular characteristics of endometrial cancer coexisting with peritoneal malignant mesothelioma in Li-Fraumeni-like syndrome
por: Chao, Angel, et al.
Publicado: (2015)